Cargando…
Human polymicrobial infections
CONTEXT: Polymicrobial diseases, caused by combinations of viruses, bacteria, fungi, and parasites, are being recognised with increasing frequency. In these infections, the presence of one micro-organism generates a niche for other pathogenic micro-organisms to colonise, one micro-organism predispos...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7119324/ https://www.ncbi.nlm.nih.gov/pubmed/15652608 http://dx.doi.org/10.1016/S0140-6736(05)17745-9 |
_version_ | 1783514749623861248 |
---|---|
author | Brogden, Kim A Guthmiller, Janet M Taylor, Christopher E |
author_facet | Brogden, Kim A Guthmiller, Janet M Taylor, Christopher E |
author_sort | Brogden, Kim A |
collection | PubMed |
description | CONTEXT: Polymicrobial diseases, caused by combinations of viruses, bacteria, fungi, and parasites, are being recognised with increasing frequency. In these infections, the presence of one micro-organism generates a niche for other pathogenic micro-organisms to colonise, one micro-organism predisposes the host to colonisation by other micro-organisms, or two or more non-pathogenic micro-organisms together cause disease. STARTING POINT: Recently, Gili Regev-Yochay (JAMA 2004; 292: 716–20) and Debby Bogaert (Lancet 2004; 363: 1871–72), and their colleagues, suggested another interaction: microbial interference—the ability of Streptococcus pneumoniae carriage to protect against Staphylococcus aureus carriage, and the inverse effect of pneumococcal conjugate vaccination on the increased carriage of Staph aureus and Staph-aureus-related disease. Strep pneumoniae carriage protected against Staph aureus carriage, and the bacterial interference could be disrupted by vaccinating children with pneumococcal conjugate vaccines that reduced nasopharyngeal carriage of vaccine-type Strep pneumoniae. WHERE NEXT: The medical community is recognising the significance of polymicrobial diseases and the major types of microbial community interactions associated with human health and disease. Many traditional therapies are just starting to take into account the polymicrobial cause of diseases and the repercussions of treatment and prevention. |
format | Online Article Text |
id | pubmed-7119324 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2005 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71193242020-04-08 Human polymicrobial infections Brogden, Kim A Guthmiller, Janet M Taylor, Christopher E Lancet Article CONTEXT: Polymicrobial diseases, caused by combinations of viruses, bacteria, fungi, and parasites, are being recognised with increasing frequency. In these infections, the presence of one micro-organism generates a niche for other pathogenic micro-organisms to colonise, one micro-organism predisposes the host to colonisation by other micro-organisms, or two or more non-pathogenic micro-organisms together cause disease. STARTING POINT: Recently, Gili Regev-Yochay (JAMA 2004; 292: 716–20) and Debby Bogaert (Lancet 2004; 363: 1871–72), and their colleagues, suggested another interaction: microbial interference—the ability of Streptococcus pneumoniae carriage to protect against Staphylococcus aureus carriage, and the inverse effect of pneumococcal conjugate vaccination on the increased carriage of Staph aureus and Staph-aureus-related disease. Strep pneumoniae carriage protected against Staph aureus carriage, and the bacterial interference could be disrupted by vaccinating children with pneumococcal conjugate vaccines that reduced nasopharyngeal carriage of vaccine-type Strep pneumoniae. WHERE NEXT: The medical community is recognising the significance of polymicrobial diseases and the major types of microbial community interactions associated with human health and disease. Many traditional therapies are just starting to take into account the polymicrobial cause of diseases and the repercussions of treatment and prevention. Elsevier Ltd. 2005-01-15 2005-01-14 /pmc/articles/PMC7119324/ /pubmed/15652608 http://dx.doi.org/10.1016/S0140-6736(05)17745-9 Text en Copyright © 2005 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Brogden, Kim A Guthmiller, Janet M Taylor, Christopher E Human polymicrobial infections |
title | Human polymicrobial infections |
title_full | Human polymicrobial infections |
title_fullStr | Human polymicrobial infections |
title_full_unstemmed | Human polymicrobial infections |
title_short | Human polymicrobial infections |
title_sort | human polymicrobial infections |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7119324/ https://www.ncbi.nlm.nih.gov/pubmed/15652608 http://dx.doi.org/10.1016/S0140-6736(05)17745-9 |
work_keys_str_mv | AT brogdenkima humanpolymicrobialinfections AT guthmillerjanetm humanpolymicrobialinfections AT taylorchristophere humanpolymicrobialinfections |